| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562e4af016953c0a80e09960559ed0d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fbc228adbb585ca02ff443dcd095b03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34fcb2b61b92e96bc4a59b241e5ae3f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce59cce5747e93470c61b45b7fc50fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c02ba2b2347d513582dcdd915aea9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad315b3d47ad5ed8f92df9f800a2cacf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705e2937ee9e7f6408a9da20043930e3 |
| publicationDate |
2011-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2385370-A1 |
| titleOfInvention |
Methods for identification and use of agents targeting cancer stem cells |
| abstract |
The invention relates to methods for identifying compounds and compositions that target cancer stem cells. In some aspects, the invention relates to treatment methods that use compounds and compositions that specifically target cancer stem cells for inhibiting the growth and/or survival of cancer stem cells in a subject in need thereof. Other aspects of the invention relate to the use of cancer stem cell biomarkers in the selection of a treatment for inhibiting the growth and/or survival of cancer stem cells in a subject in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9778264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670549-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10087258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014140072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016022721-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9534058-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9945842-B2 |
| priorityDate |
2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |